HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $112,295,744 | -5.8% | 1,091,840 | 0.0% | 4.36% | -17.2% |
| Q1 2023 | $119,163,418 | -4.1% | 1,091,840 | 0.0% | 5.26% | +18.3% |
| Q4 2022 | $124,251,392 | +83.9% | 1,091,840 | 0.0% | 4.45% | +82.0% |
| Q3 2022 | $67,574,000 | -22.4% | 1,091,840 | 0.0% | 2.44% | -26.4% |
| Q2 2022 | $87,085,000 | -24.2% | 1,091,840 | 0.0% | 3.32% | -22.7% |
| Q1 2022 | $114,872,000 | -2.4% | 1,091,840 | 0.0% | 4.30% | +7.2% |
| Q4 2021 | $117,657,000 | -31.2% | 1,091,840 | -30.1% | 4.01% | -20.3% |
| Q3 2021 | $171,024,000 | +15.1% | 1,561,290 | -1.6% | 5.03% | +7.9% |
| Q2 2021 | $148,639,000 | +1.7% | 1,587,348 | 0.0% | 4.66% | +4.4% |
| Q1 2021 | $146,100,000 | +29.1% | 1,587,348 | +2.6% | 4.46% | +12.1% |
| Q4 2020 | $113,141,000 | +7.1% | 1,546,703 | +13.8% | 3.98% | -18.5% |
| Q3 2020 | $105,600,000 | +66.3% | 1,359,420 | +19.0% | 4.88% | +48.2% |
| Q2 2020 | $63,499,000 | – | 1,142,478 | – | 3.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |